DT
Diversified Trust Portfolio holdings
AUM
$4.51B
1-Year Return
15.61%
This Quarter Return
+11.4%
1 Year Return
+15.61%
3 Year Return
+65.44%
5 Year Return
+102.62%
10 Year Return
+175.01%
AUM
$2.97B
AUM Growth
+$331M
(+13%)
Cap. Flow
+$24.5M
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
46.95%
Holding
962
New
131
Increased
368
Reduced
282
Closed
88
Top Buys
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$15.2M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$13.4M |
| 3 |
American Express
AXP
|
$4.95M |
| 4 |
Amgen
AMGN
|
$4.72M |
| 5 |
Qualcomm
QCOM
|
$4.7M |
Top Sells
| 1 |
Labcorp
LH
|
$8.72M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$8.72M |
| 3 |
S&P Global
SPGI
|
$6.82M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
$6.62M |
| 5 |
Crown Castle
CCI
|
$4.95M |
Sector Composition
| 1 | Technology | 12.22% |
| 2 | Consumer Staples | 8.26% |
| 3 | Healthcare | 6.98% |
| 4 | Financials | 6.39% |
| 5 | Consumer Discretionary | 5.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Iovance Biotherapeutics
IOVA
$868M
| $110K | ﹤0.01% |
13,512
+1,481
| +12% | +$12K |
|
802
Nordic American Tanker
NAT
$684M
| $106K | ﹤0.01% |
+25,320
| New | +$106K |
|
803
Community Health Systems
CYH
$415M
| $106K | ﹤0.01% |
33,826
+6,196
| +22% | +$19.4K |
|
804
Teekay
TK
$717M
| $104K | ﹤0.01% |
14,570
| – | – |
|
805
Unisys
UIS
$274M
| $104K | ﹤0.01% |
+18,533
| New | +$104K |
|
806
Enviri
NVRI
$940M
| $104K | ﹤0.01% |
11,571
| – | – |
|
807
CommScope
COMM
$3.6B
| $103K | ﹤0.01% |
36,604
-191
| -0.5% | -$539 |
|
808
MBIA
MBI
$388M
| $86.5K | ﹤0.01% |
14,141
+2,271
| +19% | +$13.9K |
|
809
Organogenesis Holdings
ORGO
$633M
| $85.4K | ﹤0.01% |
20,879
-9,141
| -30% | -$37.4K |
|
810
Medical Properties Trust
MPW
$2.74B
| $81.6K | ﹤0.01% |
+16,613
| New | +$81.6K |
|
811
W&T Offshore
WTI
$261M
| $72.6K | ﹤0.01% |
22,267
| – | – |
|
812
TETRA Technologies
TTI
$622M
| $72.2K | ﹤0.01% |
15,972
-350
| -2% | -$1.58K |
|
813
Rayonier Advanced Materials
RYAM
$397M
| $71.7K | ﹤0.01% |
+17,695
| New | +$71.7K |
|
814
Destination XL Group
DXLG
$67.4M
| $69.4K | ﹤0.01% |
+15,768
| New | +$69.4K |
|
815
Opendoor
OPEN
$4.72B
| $65.3K | ﹤0.01% |
14,568
-179
| -1% | -$802 |
|
|
AGEN
816
Agenus
AGEN
$134M
| $48.2K | ﹤0.01% |
2,913
-52
| -2% | -$861 |
|
817
Sutro Biopharma
STRO
$94.1M
| $48K | ﹤0.01% |
11,189
| – | – |
|
818
Fate Therapeutics
FATE
$114M
| $46K | ﹤0.01% |
12,287
| – | – |
|
|
TSVT
819
DELISTED
2seventy bio
TSVT
| $44.3K | ﹤0.01% |
10,379
| – | – |
|
820
Precigen
PGEN
$1.34B
| $39K | ﹤0.01% |
+29,126
| New | +$39K |
|
|
FSP
821
Franklin Street Properties
FSP
$176M
| $34.8K | ﹤0.01% |
13,588
-338
| -2% | -$865 |
|
822
Nektar Therapeutics
NKTR
$724M
| $34K | ﹤0.01% |
4,014
| – | – |
|
823
ThredUp
TDUP
$1.43B
| $29.1K | ﹤0.01% |
12,936
| – | – |
|
|
PDLI
824
DELISTED
PDL BioPharma, Inc.
PDLI
| $26.5K | ﹤0.01% |
11,029
| – | – |
|
825
Gannett
GCI
$622M
| $25.2K | ﹤0.01% |
10,966
| – | – |
|